Document Detail

Ventilatory Power: A Novel Index that Enhances Prognostic Assessment of Patients with Heart Failure.
MedLine Citation:
PMID:  22899767     Owner:  NLM     Status:  Publisher    
BACKGROUND: -Ventilatory efficiency (VE/VCO2 slope) is an index determined by cardiopulmonary exercise testing (CPX) which incorporates pertinent cardiac, pulmonary, and skeletal muscle physiology into a substantive composite assessment. The VE/VCO(2) slope has many applications, including utility as a well-validated prognostic gauge for heart failure (HF) patients. In this study, we combine VE/VCO(2) slope with systolic blood pressure (SBP), creating a novel index that we labeled "ventilatory power." Ventilatory power links the combined physiology inherent in the VE/VCO(2) slope to peripheral pressure, adding an additional dimension pertinent to HF assessment. Whereas the related concept of circulatory power links peak oxygen consumption (VO(2)) with peak SBP as a prognostic index, we hypothesized that ventilatory power would provide greater prognostic discrimination than VE/VO(2) slope, peak VO(2), and/or circulatory power for systolic heart failure (HF) patients. METHODS AND RESULTS: -Systolic HF patients (left ventricular ejection fraction [LVEF] ≤35%) underwent symptom-limited CPX as part of routine management and were followed for up to four years for major cardiac events (mortality, left ventricular assist device [LVAD] implantation, and heart transplantation). 875 HF patients (LVEF 26±9%; mean age 55±14) were studied. CPX indices peak VO(2), VE/VCO(2) slope, circulatory power and ventilatory power were all predictive of cardiac events (p <0.001). Multivariate analysis demonstrated that ventilatory power was the strongest indicator of prognosis. CONCLUSIONS: -While circulatory power and traditional CPX parameters can be used to predict prognosis among HF patients, ventilatory power provides relatively greater prognostic discrimination and may constitute a relatively more useful composite tool.
Daniel E Forman; Marco Guazzi; Jonathan Myers; Paul Chase; Daniel Bensimhon; Lawrence P Cahalin; Mary Ann Peberdy; Euan Ashley; Erin West; Karla M Danels; Ross Arena
Related Documents :
10980897 - Deactivation of the sympathetic nervous system in patients with chronic congestive hear...
22684377 - Gender differences in patients treated with the zotarolimus-eluting stent at a tertiary...
22424017 - Downstream procedures and outcomes after stress testing for chest pain without known co...
2468837 - Beta-blockade in acute myocardial infarction.
17573587 - Is there room for improvement in technical design and thereby a better facilitation of ...
15459597 - Serum b-type natriuretic peptide levels on admission predict not only short-term death ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-16
Journal Detail:
Title:  Circulation. Heart failure     Volume:  -     ISSN:  1941-3297     ISO Abbreviation:  Circ Heart Fail     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Brigham and Women's Hospital, Boston, MA;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardi...
Next Document:  Current Outcomes in US Children with Cardiomyopathy Listed for Heart Transplantation.